At a glance
- Originator Yamanouchi
- Class Antiasthmatics; Irritable bowel syndrome therapies
- Mechanism of Action Neurokinin 2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Irritable bowel syndrome; Urinary incontinence
Most Recent Events
- 30 Jul 1998 A preclinical study has been added to the Obstructive Airways Disease and Digestive System Disorders pharmacodynamics sections
- 17 Jul 1998 No-Development-Reported for Urinary incontinence in Japan (Unknown route)
- 20 Nov 1995 A study has been added to the Digestive System Disorders and Genitourinary Disorders pharmacodynamics section